The abstract is read at the publisher; the summary is JClub's.
In a rabbit corneal epithelial defect model, hucMSC-derived exosome-enriched extracellular vesicles shortened mean epithelial closure time to 3.50 ± 0.54 days versus 4.00 ± 0.70 days with 20% pooled human serum, but not significantly (p = 0.081).
- Why it matters: The study addresses uncertainty about whether exosome-enriched extracellular vesicles provide short-term corneal healing benefits beyond serum or supportive care, and whether observed stromal changes are meaningful.
- What they did: Fifteen rabbits were assigned to exosome-enriched extracellular vesicles (n = 6), 20% pooled human serum (n = 5), or preservative-free artificial tears (n = 4); vesicles were characterized by nanoparticle tracking and CD9 flow cytometry, and epithelial closure time plus stromal thickness and scores were assessed.
- The result: Stromal thickness was higher with exosome-enriched extracellular vesicles (p = 0.001) without significant differences in stromal oedema, fibrosis, or cellularity scores, and low post-hoc power (~22%) limited efficacy conclusions.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.